Stability and Degradation-based Proteome Profiling Reveals Cannabidiol as a Promising CDC123-eIF2γ Inhibitor for Colorectal Cancer Therapy

Journal:

Journal of the American Chemical Society

Published:

2026-01-10

DOI:

10.1021/jacs.5c20040

Affiliations:

9

Authors:

18

Go to article

Institutions	Authors	Share
Zhejiang University (ZJU), China	12.000000 12.000000	0.67
Children's Hospital, Zhejiang University School of Medicine, China	1.500000	0.08
The First People's Hospital of Hangzhou, China	1.000000	0.06
Hangzhou Medical College (HMC), China	1.000000	0.06
Yale University, United States of America (USA)	1.000000	0.06
School of Pharmaceutical Sciences, WHU, China	1.000000	0.06
Hangzhou Normal University (HZNU), China	0.500000	0.03

Interested in Pharmacology and Pharmaceutical Sciences?